With Medtronic recently launching a voluntary exchange offer to spin off its diabetes business unit, MiniMed, I've been thinking about how ordinary investors might evaluate this type of corporate action.
In this case, for Mini Medtronic MiniMed, there is a 7% valuation discount that you receive as an investor as part of the spin-off process.